|
The Company owns a 60,000-square foot pharmaceutical production
facility located in Pessac, France.
The Pessac facility and its operation are approved by the European
drug agencies and are in substantial compliance with "Good
Manufacturing Practice" ("cGMP"). The facility provides Flamel
with the capability to manufacture its cGMP-grade pharmaceutical
drugs for clinical trials utilizing its Micropump® or Medusa®
technologies.
|